Lorenzo Leys, MD
Pulmonary Disease · Washington, DCNPI 1427547710
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,629 of the $8,927 with a category attached, or 63.1%. Intuitive Surgical accounts for 96.4% of it on its own, with 9 other manufacturers making up the rest.
Across 38 payments — averaging $234.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Sanofi$93
- Insmed, Inc.$51
- Teleflex LLC$43
- Merck$36
- Bayer$26
- plus $76 from 4 others
What the payments were for
- Travel & lodging$2,83932%
- Food & beverage$4585%
- Education$5,62963%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 26 | $8,603 |
| Sanofi | 1 | $93 |
| Insmed, Inc. | 3 | $51 |
| Teleflex LLC | 1 | $43 |
| Merck | 2 | $36 |
| Bayer | 1 | $26 |
| Astellas Pharma US Inc | 1 | $22 |
| AVEO Pharmaceuticals, Inc. | 1 | $19 |
| Stemline Therapeutics Inc. | 1 | $17 |
| Pulmonx Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,256
How this compares
$8,927 in reported general payments places this provider in the 85th percentile of 56 pulmonary disease providers in District of Columbia.
See all pulmonary disease providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $17,698 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 65 | $2,145 |
| Omeprazole | 16 | $125 |
| Prednisone | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Washington
- Andrew ShorrWashington$349K
- Eric AndersonWashington$215K
- Anne OdonnellWashington$61K
- Andrew LernerWashington$19K
- Guillermo GutierrezWashington$14K
- Khalil DiabWashington$10K
- Rebecca KrochmalWashington$9K
- Steven LernerWashington$6K
- Karen FaganWashington$6K
- Leslie KingslowWashington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.